American Journal of Cardiology
Volume 105, Issue 6 , Pages 792-796 , 15 March 2010

Endothelial Nitric Oxide Synthase T-786C Mutation, A Reversible Etiology of Prinzmetal's Angina Pectoris

Received 28 September 2009 ,Revised 28 October 2009 ,Accepted 28 October 2009.

References 

  1. Nakayama M, Yoshimura M, Sakamoto T, Abe K, Yamamuro M, Shono M, et al. A −786T>C polymorphism in the endothelial nitric oxide synthase gene reduces serum nitrite/nitrate levels from the heart due to an intracoronary injection of acetylcholine. Pharmacogenet Genomics. 2006;16:339–345
  2. Yoshimura M, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, Nakamura S, et al. A T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene and coronary arterial vasomotility. Am J Cardiol. 2000;85:710–714
  3. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, et al. Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786→C and missense Glu298Asp variants. J Investig Med. 2000;48:367–374
  4. Kaneda H, Taguchi J, Kuwada Y, Hangaishi M, Aizawa T, Yamakado M, et al. Coronary artery spasm and the polymorphisms of the endothelial nitric oxide synthase gene. Circ J. 2006;70:409–413
  5. Nishijima T, Nakayama M, Yoshimura M, Abe K, Yamamuro M, Suzuki S, et al. The endothelial nitric oxide synthase gene −786T/C polymorphism is a predictive factor for reattacks of coronary spasm. Pharmacogenet Genomics. 2007;17:581–587
  6. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al. T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99:2864–2870
  7. Jia C, Liu T, Liu Z, Li M, Hu M. Joint effects of eNOS gene T-786C and ADH2 Arg47His polymorphisms on the risk of premature coronary artery disease. Thromb Res. 2007;120:679–684
  8. Nakayama M, Yoshimura M, Sakamoto T, Shimasaki Y, Nakamura S, Ito T, et al. Synergistic interaction of T-786→C polymorphism in the endothelial nitric oxide synthase gene and smoking for an enhanced risk for coronary spasm. Pharmacogenetics. 2003;13:683–688
  9. Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm—clinical features, diagnosis, pathogenesis, and treatment. J Cardiol. 2008;51:2–17
  10. Rios DL, D'Onofrio LO, Souza JK, Queiroz AM, Raduy-Maron L, Silva-Neto N, et al. Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian- and African-Brazilians. Atherosclerosis. 2007;193:135–141
  11. Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Desfossez L. Coronary artery spasm in patients with normal or near normal coronary arteries: long-term follow-up of 277 patients. Eur Heart J. 1996;17:1015–1021
  12. Keller KB, Lemberg L. Prinzmetal's angina. Am J Crit Care. 2004;13:350–354
  13. Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonell M, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995;25:333–341
  14. Balasa VV, Gruppo RA, Glueck CJ, Stroop D, Becker A, Pillow A, et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost. 1999;81:739–744
  15. Balasa VV, Gruppo RA, Glueck CJ, Wang P, Roy DR, Wall EJ, et al. Legg-Calve-Perthes disease and thrombophilia. J Bone Joint Surg Am. 2004;86-A:2642–2647
  16. Hoppmann P, Koch W, Schomig A, Kastrati A. The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions. Eur Heart J. 2004;25:335–341
  17. Liu PY, Chen JH, Li YH, Wu HL, Shi GY. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost. 2003;90:132–139
  18. Fatini C, Sofi F, Gori AM, Sticchi E, Marcucci R, Lenti M, et al. Endothelial nitric oxide synthase −786T>C, but not 894G>T and 4a4b, polymorphism influences plasma homocysteine concentrations in persons with normal vitamin status. Clin Chem. 2005;51:1159–1164
  19. Glueck CJ, Freiberg RA, Oghene J, Fontaine RN, Wang P. Association between the T-786C eNOS polymorphism and idiopathic osteonecrosis of the head of the femur. J Bone Joint Surg Am. 2007;89:2460–2468
  20. Ogawa T, Komukai K, Ogawa K, Kosuga T, Nagoshi T, Minai K, et al. High incidence of repeat anginal attacks despite treatment with calcium-channel blockers in patients with coronary spastic angina. Circ J. 2009;73:512–515
  21. Stern S, Bayes de Luna A. Coronary artery spasm: a 2009 update. Circulation. 2009;119:2531–2534
  22. Cooke JP. The pivotal role of nitric oxide for vascular health. Can J Cardiol. 2004;20(Suppl B):7B–15B
  23. MacKenzie A, Wadsworth RM. Extracellular l-arginine is required for optimal NO synthesis by eNOS and iNOS in the rat mesenteric artery wall. Br J Pharmacol. 2003;139:1487–1497
  24. Boger RH, Bode-Boger SM. The clinical pharmacology of l-arginine. Annu Rev Pharmacol Toxicol. 2001;41:79–99
  25. Glueck CJ, Haque M, Winarska M, Dharashivkar S, Fontaine RN, Zhu B, et al. Stromelysin-1 5A/6A and eNOS T-786C polymorphisms, MTHFR C677T and A1298C mutations, and cigarette-cannabis smoking: a pilot, hypothesis-generating study of gene-environment pathophysiological associations with Buerger's disease. Clin Appl Thromb/Hemost. 2006;12:427–439
  26. Rajapakse NW, Mattson DL. Role of l-arginine in nitric oxide production in health and hypertension. Clin Exp Pharmacol Physiol. 2009;36:249–255
  27. Cherney DZ, Scholey JW, Zhou J, Zimpelmann J, Kennedy C, Burns KD, et al. Endothelial nitric oxide synthase gene polymorphisms and the renal hemodynamic response to L-arginine. Kidney Int. 2009;75:327–332
  28. Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J, et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids. 2009;37:153–168
  29. Liu TH, Wu CL, Chiang CW, Lo YW, Tseng HF, Chang CK. No effect of short-term arginine supplementation on nitric oxide production, metabolism and performance in intermittent exercise in athletes. J Nutr Biochem. 2009;20:462–468
  30. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet. 2001;2:91–99
  31. Risch N, Teng J. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I (DNA pooling). Genome Res. 1998;8:1273–1288
  32. Teng J, Risch N. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases. II. Individual genotyping. Genome Res. 1999;9:234–241
  33. Newby DE, Wright RA, Dawson P, Ludlam CA, Boon NA, Fox KA, et al. The l-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man. Cardiovasc Res. 1998;38:485–492

 This study was supported by grants from the Medical Research Council, London, United Kingdom, and the Lipoprotein Research Fund of the Jewish Hospital, Cincinnati, Ohio.

PII: S0002-9149(09)02682-4

doi: 10.1016/j.amjcard.2009.10.062

American Journal of Cardiology
Volume 105, Issue 6 , Pages 792-796 , 15 March 2010

Article Tools

* Image Usage & Resolution